N/A
N=63
Backwards Walking Programme Following Hip and Knee Arthroplasty
Hip Osteoarthritis · Knee Osteoarthritis · Hip Arthroplasty · Knee Arthroplasty
Bottom Line
View on ClinicalTrials.gov: NCT04247802 ↗Enrolled (actual)
63
Serious AEs
0.0%
Results posted
Jan 2025
Primary outcome: Primary: Berg Balance Scale — 53; 52.4 Score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Backwards Walking (BW) programme (Other); Usual Care (Other)
- Age
- Older Adult · 65+ yrs
- Sex
- All
- Sponsor
- Oxford University Hospitals NHS Trust
- Primary completion
- Oct 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Berg Balance Scale |
53; 52.4 | — |
| SECONDARY Four Square Step Test |
12.8; 12.3 | — |
| SECONDARY The Two Minute Walk Test (2MWT) |
123.2; 130.8 | — |
| SECONDARY 30 Second Sit to Stand Test |
11.9; 11.3 | — |
| SECONDARY Activities-Specific Balance Confidence Scale |
88.7; 87.2 | — |
Summary
Backwards walking has been shown to improve balance and walking in patients who have knee Osteoarthritis. It is not known if these benefits may also be seen after surgery in patients who have had a hip or knee replacement because of Osteoarthritis. This study will look to see if it is possible to conduct a bigger study into how effective backwards walking may be after joint replacement. Patients who come to the Nuffield Orthopaedic Centre in Oxford for a hip or knee replacement will be invited. They will be placed into one of two groups at random: a group where they have a course of physiotherapy plus a backwards walking programme or a group where they have a course of physiotherapy. The physiotherapy will last for 12 weeks and those who take part will have two study assessments. The first will be before any treatment and patients will complete five measures and also be issued with a simple tick box diary to complete over the 12 weeks. The second assessment will be after the treatment and will involve the same five measures and the diaries will be collected in. Participants at this assessment will also be asked if they would like to take part in an interview for the study. This is to see what the patients thought of the study. During the study the researcher will record things such as how many patients say 'yes' to the study and how many participants drop out of the treatment, to understand if a bigger study could take place.
Eligibility Criteria
Inclusion Criteria
- Men and women aged 65 or older.
- Participant is willing and able to give informed consent for participation in the study.
- Participants who have received a primary unilateral hip or knee arthroplasty due to osteoarthritis.
Exclusion Criteria
- Post-operative weight bearing restrictions.
- Post-operative complications such as infection, a deep vein thrombosis or pulmonary embolism, or failure of the wound to heal.
- Inability to undertake a backwards walking programme due to conditions such as severe cardiovascular or pulmonary disease (New York Heart Association III-IV).
- Severe dementia or communication difficulties that would prevent completion of study assessments.
- Any neurological condition.
- Further planned treatment on the same or contralateral hip or knee within the next 6 months.
- Registered as visually impaired.
Data sourced from ClinicalTrials.gov (NCT04247802). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.